Literature DB >> 20568493

Trimetazidine: new French pharmacovigilance data.

.   

Abstract

The authors of a French pharmacovigilance study examined more than 300 adverse effects due to trimetazidine, reported up to the beginning of 2008. This study yielded useful information about the adverse effects of trimetazidine other than those already known: thrombocytopenia and extrapyramidal syndromes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20568493

Source DB:  PubMed          Journal:  Prescrire Int        ISSN: 1167-7422


  1 in total

1.  [Idaptan(®) (trimetazidine): the panacea].

Authors:  Mara Sempere Manuel; Patricia Roth Damas; José Luis Gonzálvez Perales; Vicente Palop Larrea
Journal:  Aten Primaria       Date:  2013-01-17       Impact factor: 1.137

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.